BG Medicine, FDA Partner on Liver Toxicity Biomarker Study | GenomeWeb

NEW YORK, Oct. 25 (GenomeWeb News) - BG Medicine said today that it has submitted a cooperative research and development agreement with the US Food and Drug Administration's National Center for Toxicological Research for a project to discover biomarkers of human hepatotoxicity.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.